Pregnancy and systemic lupus erythematosus;Grossesse et lupus erythemateux systemique

Annales de Medecine Interne

Volumn 150, Issue 5, 1999, Pages 408-418

  Wechsler, Bertrand ^a   Thi Huong Du, L E ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Pregnancy; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; CREATININE; HEPARIN; PREDNISONE; ANTIMALARIAL AGENT; IMMUNOSUPPRESSIVE AGENT;

CONFERENCE PAPER; CREATININE BLOOD LEVEL; DISEASE CONTROL; FEMALE; HIGH RISK POPULATION; HUMAN; MATERNAL HYPERTENSION; PREGNANCY; PROGNOSIS; PROPHYLAXIS; PUERPERIUM; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ADULT; ANTIPHOSPHOLIPID SYNDROME; CESAREAN SECTION; COMPARATIVE STUDY; DRUG EFFECT; FETUS; FETUS DEATH; FETUS DISEASE; INFANT MORTALITY; NEWBORN; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURITY; REVIEW; RISK FACTOR;

ABORTION, SPONTANEOUS; ADRENAL CORTEX HORMONES; ADULT; ANTIMALARIALS; ANTIPHOSPHOLIPID SYNDROME; CESAREAN SECTION; FEMALE; FETAL DEATH; FETAL DISEASES; FETUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; RISK FACTORS;

EID: 0033192080     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (111)

1. KITRIDOU RC, MINTZ G: Pregnancy in lupus: The mother in SLE. Dubois' Lupus Erythematosus. Wallace DJ, Hahn BH, eds. 4th Ed. Philadelphia: Lea and Febiger, 1999: 487-507.
2. BOUMPAS DT, AUSTIN HA, VAUGHAN EM, YARBORO CH, KLIPPEL JH, BALOW JE: Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med, 1993; 119: 366-9.
3. MCDERMOTT EM, POWELL RJ: Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide. Ann Rheum Dis, 1996; 55: 224-9.
4. MOK CC, LAU CS, WONG RWS: Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum, 1998; 41: 831-7.
5. LE THI HUONG D, WECHSLER B, PIETTE JC, ARFI S, GALLINARI C, DARBOIS Y et al.: Risks of ovulation-induction therapy in systemic lupus erythematosus. Br J Rheumatol, 1996; 35: 1184-6.
6. BEN-CHETRIT A, BEN-CHETRIT E: Systemic lupus erythematosus induced by ovulation induction treatment. Arthritis Rheum, 1994; 37: 1614-7.
7. CASOLI P, TUMIATI B, LA SALA G: Fatal exacerbation of systemic lupus erythematosus after induction of ovulation. J Rheumatol, 1997; 24: 1639-40.
8. WECHSLER B, LE THI HUONG D, VAUTHIER-BROUZES D, LEFEBVRE G, COMPEL A, PIETTE JC: Can we advise ovulation induction in patients with SLE? Scand J Rheumatol, 1998; 27: Suppl 53-9.
9. MIYAGAWA S, SHIRAI T, SHIMAMOTO I, ICHIJO M, UEKI H: Worsening of systemic lupus erythematosus-associated thrombocytopenia after administration of gonadotropin-releasing hormone analog. Arthritis Rheum, 1994; 37: 1708-9.
10. LOCKSHIN MD, REINITZ E, DRUZIN ML, MURRMAN M, ESTES D: Lupus pregnancy: case control study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med, 1984; 77: 893-8.
11. MINTZ G, Niz J, GUTTIEREZ G, GARCIA-ALONSO A, KARCHMER S: Prospective study of pregnancy in systemic lupus erythematosus: results of a multidisciplinary approach. J Rheumatol, 1986; 13: 732-9.
12. UROWITZ MB, GLADMAN DD, FAREWELL VT, STEWART J, MCDONALD J: Lupus and pregnancy studies. Arthritis Rheum, 1993; 10: 1392-7.
13. PETRI M, HOWARD D, REPKE J: Frequency of lupus flare in pregnancy. The Hopkins lupus pregnancy center experience. Arthritis Rheum, 1991; 34: 1538-45.
14. RUIZ-IRASTORZA G, LIMA F, ALVES J, KHAMASHTA MA, SIMPSON J, HUGHES GRV et al.: Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol, 1996; 35: 133-8.
15. LE THI HUONG D, WECHSLER B, PIETTE JC, BLÉTRY O, GODEAU P: Pregnancy and its outcome in systemic lupus erythematosus. Q J Med, 1994; 87: 721-9.
16. MINAKAMI H, IDEI S, KOIKE T, TAMADA T, YASUDA Y, HIROTA N: Active lupus and preeclampsia: A life threatening combination. J Rheumatol, 1994; 21: 1562-3.
17. BELLER FK, DAME WR, EBERT C: Pregnancy induced hypertension complicated by thrombocytopenia haemolysis and elevated liver enzymes (HELLP) Syndrome. Aust NZJ Obstet Gynaecol, 1985; 25: 83.
18. MAGANN EF, PERRY KG, MEYDRECH EF, HARRIS RL, CHAUHAN SP, MARTIN JN: Postpartum corticosteroids: Accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol, 1994; 171: 1154-8.
19. ALSUKYMAN OM, CASTRO MA, ZUCKERMAN E, MCGEHEE W, GOODWIN TM: Preeclampsia and liver infarction in early pregnancy associated with antiphospholid syndrome. Obstet Gynecol, 1996; 88: 644-6.
20. ABRAMSON SB, BUYON JP: Activation of the complement pathway: comparison of normal pregnancy, preeclampsia and systemic lupus erythematosus during pregnancy. Am J Reprod Immunol, 1992; 28: 183-7.
21. BUYON JP, TAMERIUS J, ORDORICA S, YOUNG B, ABRAMSON SB: Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy. Arthritis Rheum, 1992; 35: 55-61.
22. BUYON JP, CRONSTEIN BN, MORRIS M, TANNER M, WEISSMANN G: Serum complement values (C3 and C4) to differenciate between systemic lupus activity and preeclampsia. Am J Med, 1986; 81: 194-200.
23. PETRI M: Systemic lupus erythematosus and pregnancy. Rheum Clin Dis North Am, 1994; 20: 87-118.
24. TOMER Y, VIEGAS OAC, SWISSA M, KOH SCL, SHOENFELD Y: Levels of lupus autoantibodies in pregnant SLE patients: Correlations with disease activity and pregnancy outcome. Clin Exp Rheumatol, 1996; 14: 275-80.
25. JUNGERS P, CHAUVEAU D: Pregnancy in renal disease. Kidney Int, 1997; 52: 871-85.
26. RAHMAN P, GLADMAN DD, UROWITZ MB: Clinical predictors of fetal outcome in systemic lupus erythematosus. J Rheumatol, 1998; 25: 1526-30.
27. IMBASCIATI E, SURIAN M, BOTTINO, COSCI P, COLUSSI G, AMBROSO GC et al.: Lupus nephritis and pregnancy. A study of 26 pregnancies in patients with systemic lupus erythematosus and nephritis. Nephron, 1984; 36: 46-51.
28. CAMERON JS, HICKS J: Pregnancy in patients with preexisting glomerular disease. Contrib Nephrol, 1984; 37: 149-56.
29. OVIASU E, HICKS J, CAMERON JS: The outcome of pregnancy in women with lupus nephritis. Lupus, 1991; 1: 19-25.
30. PACKHAM DK, LAM SS, NICHOLLS K, FAIRLEY KF, KINCAID-SMITH PS: Lupus nephritis and pregnancy. Q J Med, 1992; 83: 315-24.
31. LIMA F, KHAMASHTA MA, BUCHANAN NMM, KERSLAKE S, HUNT BJ, HUGHES GRV: A study of sixty pregnancies in the patients with the antiphospholipid syndrome. Clin Exp Rheumatol, 1996; 14: 131-6.
32. JUNGERS P, CHAUVEAU D, CHOUKROUN G, MOYNOT A, SKHIRI H HP, FORGET D et al: Pregnancy in women with impaired renal function, din Nephrol, 1997; 21 (47): 281-8.
33. HUSSEIN MM, Moou JM, ROUJOULEH H: Cyclosporin- in the treatment of lupus nephritis including two patients treated during pregnancy, din Nephrol, 1993; 40: 160-3.
34. TOYOTA T, YORIOKA N, TAKAHASHI N, MORIISHI M, KAWANISHI H, TSUCHIYA T et al.: Successful birth in a hemodialysis patient with SLE. Nephron, 1993; 65: 331-2.
35. Lê Tin HUONG D, WECHSLER B, VAUTHIER-BROUZES D, BEAUFILS H, SEEBACHER J, DARBOIS Y et al.: La grossesse au cours de la néphropathie lupique. Rev Méd Interne, 1998; 19: 75S.
36. LÊ THI HUONG DU, WECHSLER B, PIETTE JC, BLÉTRY O, et le Groupe d'Etude sur la Grossesse Lupique. Registre français des grossesses lupiques. Le bilan. Rev Méd Interne, 1994; 15: 305-17.
37. OSTENSEN M: Treatment with immunosuppressive and disease modifying drugs during pregnancy and lactation. Am J Reprod Immunol, 1992; 28: 148-52.
38. PARKE A, WEST B: Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol, 1996; 23: 1715-8.
39. BUCHANAN NM, TOUBI E, KHAMASHTA MA, LIMA F, KERSLAKE S, HUGHES GRV: Hydroxychloroquine and lupus pregnancy: Review of a series of 36 cases. Ann Rheum Dis, 1996; 55: 486-8.
40. PARKE AL: Antimalarial drug in pregnancy. Scand J Rheumatol, 1998; 27: Suppl 125-7.
41. BUCKLEY LM, BULLABOY CA, LEICHTMAN L, MARQUEZ M: Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum, 1997; 40: 971-3.
42. ROUBENOFF R, HOYT J, PETRI M, HOCHBERG MC, HELLMAN DB: Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility. Semin Arthritis Rheum, 1988; 18: 88-110.
43. RAMSEY-GOLDMAN R: The risk of cytotoxic drugs during pregnancy. Scand J Rheumatol, 1998; 27: Suppl 133-5.
44. LAMARQUE V, LELEU MF, MONKA C, KRUPP P: Analysis of 629 pregnancy outcomes in transplant recipients treared with Sandimmun. Transplantation Proceed, 1997; 29: 2480.
45. PETRI M, HOWARD D, REPKE J, GOLDMAN DW: The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am J Reprod Immunol, 1992; 28: 188-91.
46. WONG KL, CHAN FY, LEE CP. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med, 1991; 151: 269-73.
47. LÊ THI HUONG D, WECHSLER B, PIETTE JC, VAUTHIER-BROUZES D, SEEBACHER J, LEFÈBVRE G et al.: Programme de planification de la grossesse au cours du lupus érythémateux disséminé. Presse Méd, 1996; 25: 711-7.
48. MUSSENT HC, SWAAK TJG: Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J Rheumatol, 1986; 17: 771-6.
49. RAYBURN WF: Glucocorticoid Therapy for Rheumatic Diseases Maternal/Fetal, and Breast-Feeding Considerations. Am J Reprod Immunol, 1992; 28: 138-40.
50. LOCKSHIN MD, SAMMARITANO LR: Corticosteroids during pregnancy. Scand J Rheitmatol, 1998; 27: Suppl 136-8.
51. COWCHOCK FS, REECE EA, BALABAN D, BRANCH DW, PLOUFFE L: Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol, 1992; 766: 1318-23.
52. LASKIN ÇA, BOMBARDIER C, HANNAH ME, MANDEL FP, RITCHIE JW, FAREWELL V et al: Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med, 1997; 337: 148-53.
53. PETRI M: Hopkins lupus pregnancy center: 1987 to 1996. Rheum Dis Clin North Am, 1997; 23: 1-13.
54. LÊ THI HUOXG D, WECHSLER B, VAUTIIIER-BROUZES D, SEEBACHER J, LEFÈ̀BVRE G, BLÉTRY O et al.: Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol, 1997; 36: 772-7.
55. DERCOLE C, BOUBLI L, FRANCK J, CASTA M, HARLE JR, CHAGNON C et al: Recurrent congenital toxoplasmosis in a woman with lupus erythematosus. Prenatal Diag, 1995; 75: 1171-5.
56. WECHSLER B, LE THI HUONG Du, VIGNES B, PIETTE JC, CHOMETTE G, GODEAU P: Toxoplasmose et lupus. A propos de 4 observations. Ami Méd Interne, 1986; 137: 324-30.
57. HAYES K, SYMINGTON G, MACKAY IR: Maternai immunosuppression and cytomegalovirus infection of the fœtus. Amt NZ J Med, 1989; 9: 430-3.
58. RAMSEY-GOLDMAN R, HOM D, DENG J, CASTERLINE ZIEGLER G, KAHL LE, STEEN VD et al: Anti-SSA antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum, 1986; 29: 1269-73.
59. LEVARTOVSKY D, BELMONT HM, BUYON J, KOLODNY E, ABRAMSON S: Hirschprung's disease: a new form of neonatal lupus erythematosus? Arthritis Rheum, 1994; 37: S317.
60. CHAMEIDES L, TRUEX RC, VETTER V, RASHKIND WJ, GALIOTO FM, NOONAN JA: Association of maternal lupus erythematosus with congenital heart block. N Engl J Med, 1977; 297: 1204-7.
61. MCCUE CM, MANTAKAS ME, TINGELSTAD JB, RUDDY S: Congenital heart block in newborns of mothers with connective tissue disease. Circulation, 1977; 56: 82-90.
62. MCCUNE AB, WESTON WL, LEE LA: Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med, 1987; 706: 518-23.
63. WALTUCK J, BUYON JP: Autoantibody-Associated Congenital Heart Block Outcome in Mothers and Children. Ann Intern Med, 1994; 720: 544-51.
64. JULKUNEN H, KURKI P, KAAJA R, HEIKKILA R, IMMONEN I, CHAN EKL et al: Isolated congenital heart block. Long term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum, 1993; 36: 1588-98.
65. PRESS J, UZIEL Y, LAXER RM, LUY L, HAMILTON RM, SILVERMAN ED: Long-term outcome of mothers of children with complete congenital heart block. Am J Med, 1996; 100: 328-32.
66. BOUTJDIR M, CHEN L, ZHANH ZH, TSENG CE, DIDOVATO F, RASHBAUM W et al: Arrhythmogenicity of IgG and anti-52-kD SSA/RO affinity-purified antibodies from mothers of children with congenital heart block. Circ Res, 1997; 80: 354-62.
67. LITSEY SE, NOONAN JA, O'CONNOR WN, COTTRILL CM, MITCHELL B: Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med, 1985; 312: 98-100.
68. TAYLOR PV, SCOTT JS, GERLIS LM, ESSCUER E, SCOTT O: Maternal antibodies against fetal cardiac antigens in congenital complete heart block. N Engl J Med, 1986; 315: 667-72.
69. HERREMAN G, FERME I, MOREL S, BATISSE J, PHAT VN, MEYER O: Mort ftale par myocardite et bloc auriculoventriculaire congénital isolé. Presse Méd, 1985; 14: 1547-50.
70. BRUCATO A, FRANCESCHINI F, BUYON JP: Neonatal lupus: long term outcomes of mothers and children and recurrence rate. Clin Exp Rheumatol, 1997; 75: 467-73.
71. WATSON RM, LANE AT, BARNETT NK, BIAS WB, ARNETT FC, PROVOST TT: Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine, 1984; 63: 362-78.
72. OLAH KS, GEE H: Fetal heart block associated with maternal anti-Ro (SS-A) antibody current management. A review. Br J Obstet Gynecol, 1991; 98: 751-5.
73. SILVERMAN E, MAMULA M, HARDIN JA, LAXER R: Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus. J Rheumatol, 1991; 18: 120-4.
74. PROVOST TT, WATSON R, GAMMON WR, RADOWSKY M, HARLEY JB, REICHLIN M: The neonatal lupus syndrome associated with Ul RNP (nRNP) antibodies. N Engl J Med, 1987; 316: 1135-8.
75. MCCARRON DP, HELLMANN DB, TRAILL TA, WATSON RM: Neonatal lupus erythematosus syndrome: late detection of isolated heart block. J Rheumatol, 1993; 20: 1212-4.
76. SlMMONS-O'BRIEN E, CHEN S, WATSON R, ANTONI C, PETRI M, HOCHBERG M et al.: One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine, 1995; 74: 109-130.
77. COOLEY HM, KEECH CL, MELNY BJ, MENAHEM S, MORAHAN G, KAY TWH: Monozygotic twins discordant for congenital complete heart block. Arthritis Rheum, 1997; 40: 381-4.
78. WATSON RM, SCHEEL JN, PETRI M, KAN JS, PROVOST TT, RATRIE H et al.: Neonatal Lupus Erythematosus Report of Serological and Immunogenetic Studies in Twins Discordant for Congenital Heart Block. Br J Dermatol, 1994; 130: 342-8.
79. CARREIRA P, GUTTIEREZ-LARRAYA F, GOMEZ-REINO JJ: Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus. J Rheumatol, 1993; 20: 1204-7.
80. VAN DER LEU JN, VISSER GHA, BINK-BOELKENS MTE, MEILOF JF, KALLENBERG COM: Successful outcome of pregnancy after treatment of maternal anti-Ro (SSA) antibodies with immunosuppressive therapy and plasmapheresis. Prenatal Diagnosis, 1994; 14: 1003-7.
81. BUYON JP: Neonatal lupus and autoantibodies reactive with SSA/Ro-SSB/La. Scand J Rheumatol, 1998; 27: Suppl23-30.
82. COPEL JA, BUYON JP, KLEINMAN CS: Successful in utero therapy of fetal heart block. Am J Obstet Gynecol, 1995; 173: 1384-90.
83. EPSTEIN AL, HUHTA JC, GLICKMAN JD, ZACHIAN VA: Transient reversal of congenital complete heart block. Arthritis Rheum, 1994; 37: S317.
84. RIDER LG, BUYON JP, RUTLEDGE J, SHERRY DD: Treatment of neonatal lupus: case report and review of the literature. J Rheumatol, 1993; 20: 1208-11.
85. SILVERMAN E: Congenital heart block and neonatal lupus erythematosus: prevention is the goal. J Rheumatol, 1993; 20: 1101-4.
86. WEBER JC : Les complications obstétricales du syndrome des antiphospholipides. Rev Méd Interne, 1997; 18: 240-9.
87. RUIZ-IRASTORZA G, KHAMASHTA M, HUGHES G: Treatment of the antiphospholip syndrome in pregnancy. Scand J Rheumatol, 1998; 27; Suppl44-7.
88. BRANCH DW, SILVER RM: Criteria for antiphospholipd syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus, 1996; 5: 409-13.
89. KUTTEH WH, LYDA EC, ABRAHAM SM, WACHOLTZ MC: Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus. Fertil Steril, 1993; 60: 449-55.
90. RAMSEY-GOLDMAN R, KUTZER JE, KULLER LH, GUZICK D, BETTS CARPENTER A, MEDSGER TA: Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. Am J Epidemiol, 1993; 138: 1057-69.
91. NAYAR R, LAGE JM: Placental changes in a first trimester missed abortion in maternal lupus erythematosus with antiphospholipid syndrome. Hum Pathol, 1996; 27: 201-6.
92. HASEGAWA I, TAKAKUWA K, GOTO S, YAMADA K, SEKIZUKA N, KANAZAWA K et al. Effectiveness of prednisone/aspirin therapy for recurrent aborters with antiphospholipid antibody. Hum Reprod, 1992; 7: 203-7.
93. RAI R, CLIFFORD K, COHEN H, REGAN L: High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod, 1995; 10: 3301-4.
94. ROSOVE MH, TABSH K, WASSERSTRUM N, HOWARD P, HAHN BH, KALUNIAN KC: Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol, 1990; 75: 630-4.
95. KUTTEH WH: Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol, 1996; 174: 1584-9.
96. RAI R, COHEN H, DAVE M, REGAN L: Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ, 1997; 314: 253-7.
97. BRANCH DW, SILVER RM, BLACKWELL JL, READING JC, SCOTT JR: Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol, 1992; 80: 614-20.
98. SCHIFF E, MASHIACH S: The use of low dose aspirin in pregnancy. Am J Reprod Immunol, 1992; 28: 153-6.
99. SIBAI BM, CARITIS SN, THOM E, KLEBANOFF M, MCNELLIS D, ROCCO L et al.: Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med, 1993; 329: 1213-8.
100. LE THI HUONG D, WECHSLER B, EDELMAN P, FOURNIE A, LE TALLEC Y, PIETTE JC et al.: Postpartum cerebral infarction associated with aspirin withdrawal in the antiphospholid antibody syndrome. J Rheumatol, 1993; 30: 1229-32.
101. COMMITTEE ON DRUGS AMERICAN ACADEMY OF PEDIATRICS: Transfer of drugs and other chemicals into human milk. Pediatrics, 1989; 84: 924-36.
102. BUCHANAN NM, KHAMASHTA MA, MORTON KE, KERSLAKE S, BAGULEY EA, HUGHES GR: A study of 100 high risk lupus pregnancies. Am J Reprod Immunol, 1992; 28: 192-4.
103. ZURIER RB, ARGYROS TG, URMAN JD, WARREN J, ROTHFIELD NF: Systemic lupus erythematosus: management during pregnancy. Obstet Gynecol, 1978; 57: 178-80.
104. ESTES D, LARSON DL: Systemic lupus erythematosus and pregnancy. Clin Obstet Gynecol, 1965; 8: 307-12.
105. TOZMAN EC, UROWITZ MB, GLADMAN DD: Systemic lupus erythematosus and pregnancy. J Rheumatol, 1980; 7: 624-32.
106. HAYSLETT JP, LYNN RI: Effect of pregnancy in patients with lupus nephropathy. Kidney Int, 1980; 18: 207-20.
107. JUNGERS P, DOUGADOS M, PELISSIER C, KUTTENN F, TRON F, LESAVRE P et al.: Lupus nephropathy and pregnancy. Arch Intent Med, 1982; 742: 771-6.
108. FRAGA A, MINTZ G, OROZCO J, OROZCO JH: Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J Rheitmatol, 1974; 1: 293-8.
109. ZULMAN JI, TALAL N, HUFFMAN GS, EPSTEIN WV: Problems associated.with the management of pregnancies in patients with systemic lupus erythematosus. J Rlmnnatol, 1980; 7: 37-49.
110. BEAR R: Pregnancy and lupus nephropathy. Obstet Gynecol, 1976; 47: 715-8.
111. FINE LG, BARNETT EV, DANOVITCH GM, NISSENSON AR, CONTROLLY ME, LIEB ME et al: Systemic lupus erythematosus in pregnancy. Ann Intern Med, 1981; 94: 667-77.